Broker Tips
Berenberg boosts target price for On The Beach after succesful year
Analysts at Berenberg reiterated their ‘buy’ rating of On The Beach (OTB) on Friday telling clients they expect the company’s payout to increase by 25% in 2018, highlighting prospects for stronger-than-expected organic growth and the company's drive to expand abroad.
Broker tips: Relx, GSK, TalkTalk
Relx, formerly Reed Elsevier, got a boost on Friday as Deutsche Bank bumped the stock up to 'buy' from 'hold' and hiked the price target to 1,750p from 1,630p, saying the share price correction has created an opportunity.
Friday broker round-up
Glaxosmithkline: Berenberg reiterates buy with a target price of 1,705p.
Deutsche Bank upgrades Relx as selloff creates buying opportunity
Relx, formerly Reed Elsevier, got a boost on Friday as Deutsche Bank bumped the stock up to 'buy' from 'hold' and hiked the price target to 1,750p from 1,630p, saying the share price correction has created an opportunity.
Kepler upgrades Glaxo, says worst-case scenario priced in
Kepler Cheuvreux upped its stance on pharmaceuticals giant GlaxoSmithKline to 'hold' from 'reduce' on Friday, lifting the price target to 1,360p from 1,340p as it said the worst-case scenario for the stock was now priced in.
Talktalk hits new low as analysts clash, institutions 'revolt'
Talktalk's profit warning and proposed placing elicited a mixed reaction among City analysts and institutional investors, with Goldman Sachs unimpressed and reiterating its 'sell' recommendation, while RBC Capital Markets hoped this was the beginning of a new era.